Healthcare costs of fast-acting insulin analogues vs. short-acting human insulin in combination with long-acting insulin analogues for Danish patients with type 2 diabetes

被引：0
|
作者：
Gundgaard, J. [1 ]
Christensen, T. [2 ]
Thomsen, T. [2 ]
机构：
[1] COWI AS, Hlth & Econ, Kongens Lyngby, Denmark
[2] Novo Nordisk AS, Virum, Denmark
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1061
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Short-acting insulin analogues vs. human insulin for diabetes
    Schooff, M
    Ehlers, K
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (05) : 805 - 807
  • [2] Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis
    Mannucci, E.
    Monami, M.
    Marchionni, N.
    DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 53 - 59
  • [3] Costs Associated With Long-Acting Insulin Analogues in Patients With Diabetes
    Alemayehu, Berhanu
    Speiser, Jessica
    Bloudek, Lisa
    Sarnes, Evelyn
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (08): : SP265 - +
  • [4] Long-acting insulin analogues
    Holt, R
    DIABETES OBESITY & METABOLISM, 2003, 5 (04): : 270 - 270
  • [5] The utilisation of long-acting insulin analogues and intermediate-acting insulin in patients with type 2 diabetes in the United Kingdom
    Brunetti, V. C.
    Yu, O. H. Y.
    Platt, R. W.
    Filion, K. B.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S146 - S146
  • [6] Direct costs of care and clinical outcomes in patients with type 2 diabetes switching between short-acting human insulin and rapid-acting insulin analogues
    Cleall, S.
    Reaney, M.
    Tentolouris, N.
    Cypryk, K.
    Petzinger, U.
    Koivisto, V.
    Jecht, M.
    DIABETOLOGIA, 2011, 54 : S414 - S414
  • [7] A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin
    Adachi, A
    Fukunaga, A
    Horikawa, T
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (08) : 597 - 599
  • [8] Subcutaneous fast-acting insulin analogues ± long-acting insulin vs IV insulin infusion in DKA: updated meta-analysis of randomised trials
    Lim, Beng Leong
    Lee, Wei Feng
    Chung, Yan Ee Lynette
    Lee, Berlin
    Loo, Kee Vooi
    ENDOCRINE, 2025, 87 (03) : 920 - 932
  • [9] Healthcare costs of long-acting insulin analogues compared with NPH insulin in patients using a basal regimen: a Danish perspective
    Gundgaard, J.
    Aagren, M.
    Thomsen, T. L.
    DIABETOLOGIA, 2009, 52 : S94 - S95
  • [10] Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
    Horvath, K.
    Jeitler, K.
    Berghold, A.
    Ebrahim, S. H.
    Gratzer, T. W.
    Plank, J.
    Kaiser, T.
    Pieber, T. R.
    Siebenhofer, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):
12345